Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 percent compared to standard treatment, according to new findings. The research, led by Imperial College London and ...

Venous leg ulcers are common and distressing, affecting around 1 in 300 adults in the UK. They are open, often painful, sores on the leg that take months to heal and can develop after a minor injury.

Venous leg ulcers are common and distressing, affecting around 1 in 300 adults in the UK. They are open, often painful, sores on the leg that take months to heal and can develop after a minor injury.

Venous ulcers are the most common type of leg ulcers, but that doesn't make them any less troubling. Most often found just above the ankle, these non-healing skin wounds can take on many shapes and ...

The medical technologies advisory committee considered evidence on compression products for treating venous leg ulcers. Evidence was considered from several sources to determine whether price ...

In normal conditions, contraction of lower extremity muscles and working intraluminal valves promote the forward flow of blood within veins. In venous insufficiency, reflux and/or obstruction in the ...

After proving acellular matrices are effective in treating diabetic foot ulcers, researchers are now eyeing the treatment as a tool for healing venous leg ulcers. Typically, VLU treatment includes ...

When compared with normal care, treating a leg ulcer with dressings impregnated with honey did not significantly improve the rate of healing, but did lead to a significantly increased number of ...

AOTI, Inc. (($GB:AOTI)) announced an update on their ongoing clinical study. The clinical study titled A Multi-national, Prospective, Randomized, ...

THE pathogenesis of chronic stasis ulcer of the leg is not well understood. It is generally accepted that an important factor is excessive venous pressure in the leg. In strong support of this concept ...

Shire Plc abandoned development of its Dermagraft skin substitute for the treatment of leg ulcers after the product failed in a trial, denting the company's plans to expand the treatment into a $500 ...